Welcome to Crene Biotechnology!


Product :


Dasatinib 302962-49-8
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:Dasatinib Purity:98% min
CAS NO:302962-49-8 Solubility:DMSO : 35.35 mg/mL (72.44 mM)
Molecular Formula:C22H26ClN7O2S Package:Package according to customer requirements
Molecular Weight:488.006 Storage:Store at -20℃
Quality control

Dasatinib, previously known as BMS-354825, is a cancer drug. Dasatinib is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the "Philadelphia chromosome") and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers, including advanced prostate cancer. 

Appearance & Physical State: pale-yellow solid
Density: 1.408g/cm3
Melting Point: 275-286ºC



Related Products:  

Afatinib dimaleate; Neratinib; Bosutinib; Bosutinib Intermediates; Bosutinib Monohydrate; Saracatinib; NVP-BHG712; PP1; PP2; A-966492; G007-LK; SU6656; Tirbanibulin; TPX-0005; Afatinib

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2021 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China